| 000 | 01901 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515145329.0 | ||
| 264 | 0 | _c20081222 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBéres, Bernát János | |
| 245 | 0 | 0 |
_aAnalysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cNov 2008 |
||
| 300 |
_a829-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdenosine Diphosphate |
| 650 | 0 | 4 |
_aAdenosine Monophosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAspirin |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCollagen |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorepinephrine _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xblood |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xblood |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y12 |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aTóth-Zsámboki, Emese | |
| 700 | 1 | _aVargová, Katarína | |
| 700 | 1 | _aLászló, Adám | |
| 700 | 1 | _aMasszi, Tamás | |
| 700 | 1 | _aKerecsen, Gábor | |
| 700 | 1 | _aPréda, István | |
| 700 | 1 | _aKiss, Róbert Gábor | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 100 _gno. 5 _gp. 829-38 |
|
| 999 |
_c18450548 _d18450548 |
||